Febrile Neutropenia Research Report 2025: Market Projected to Reach USD 23.7 Billion by 2032, Driven by Increasing Cancer Incidence and Advancements in Supportive Care
March 14, 2025 12:28 ET
|
Research and Markets
Dublin, March 14, 2025 (GLOBE NEWSWIRE) -- The "Febrile Neutropenia Market" report has been added to ResearchAndMarkets.com's offering.The global febrile neutropenia market is experiencing robust...
Immunotoxins Market Size, Share & Trends Analysis Report 2025: Diphtheria Toxin (DT) Dominated with Market Share of 43.91% in 2024 - Forecasts to 2030
March 10, 2025 05:04 ET
|
Research and Markets
Dublin, March 10, 2025 (GLOBE NEWSWIRE) -- The "Immunotoxins Market Size, Share & Trends Analysis Report By Product, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030"...
Plaque Psoriasis Market Research 2024-2034: Environmental and Genetic Factors Boost Demand, Investments in Medical R&D Catalyze Innovations
January 23, 2025 04:44 ET
|
Research and Markets
Dublin, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The "Plaque Psoriasis Market by Treatment, by Route of Administration, by End-user, and by Region" report has been added to ResearchAndMarkets.com's...
Immunotoxins Market Trends and Regional Business Opportunities, 2024-2034: Diphtheria Toxin-Based Immunotoxins Lead Revenue, Pseudomonas Exotoxins Show Rapid Growth Potential
January 09, 2025 04:52 ET
|
Research and Markets
Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Immunotoxins Market by Product, by Application, by End-User, and by Region" report has been added to ResearchAndMarkets.com's offering. This...
Plaque Psoriasis Research Report 2024: 7 Major Market and 61 Additional Country Market Analysis and Sales Forecasts 2020-2030
November 18, 2024 10:55 ET
|
Research and Markets
Dublin, Nov. 18, 2024 (GLOBE NEWSWIRE) -- The "Plaque Psoriasis: 68-Market Analysis and Sales Forecast" report has been added to ResearchAndMarkets.com's offering.The analyst estimates that sales...
Immunology Biosimilars Market Research 2024-2030, Profiles of Key Players - F. Hoffmann-La Roche, Merck, Eli Lily,. Pfizer, Novartis, Teva, Boehringer Ingelheim, Celltrion, Samsungbioepis, Amgen
November 14, 2024 07:14 ET
|
Research and Markets
Dublin, Nov. 14, 2024 (GLOBE NEWSWIRE) -- The "Immunology Biosimilars Market (2024 Edition): Analysis By Indication (Arthritis, Irritable Bowel Disease, Other Indications), By Distribution Channel,...
Graft Versus Host Disease (GvHD) Treatment Industry Forecast Report, 2024-2032 - Global Market Size Forecast to Double, with Emerging Markets Offering Substantial Growth Potential
November 07, 2024 09:47 ET
|
Research and Markets
Dublin, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease (GvHD) Treatment Market Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.The graft...
Understanding the United States Psoriasis Patient Experience to Make Informed Business Decisions, Identify Opportunities, and Understand Potential Challenges
October 25, 2024 04:05 ET
|
Research and Markets
Dublin, Oct. 25, 2024 (GLOBE NEWSWIRE) -- The "Psoriasis in the United States: Understanding the Psoriasis Patient Experience" report has been added to ResearchAndMarkets.com's offering. This...
Chronic Urticaria Competitive Landscape Assessment 2024: Regeneron/Sanofi (Dupixent) and Genentech/Novartis (Xolair) Dominate the Market
October 04, 2024 05:44 ET
|
Research and Markets
Dublin, Oct. 04, 2024 (GLOBE NEWSWIRE) -- The "Chronic Urticaria: Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.This report provides a data-driven overview of...
Allergy Treatment - Global Strategic Business Report to 2030: Increasing Availability of OTC Allergy Medications, Advances in Biologic Therapies Propel Growth
July 26, 2024 06:23 ET
|
Research and Markets
Dublin, July 26, 2024 (GLOBE NEWSWIRE) -- The "Allergy Treatment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Allergy...